Secondhand Smoke a Danger to Health – Germany Must Take Action
German Cancer Research Center presents a new study
Tobacco smoke in enclosed spaces is not simply a nuisance: it is a threat to health with fatal consequences. This is the conclusion reached by the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) in its latest publication.
“Secondhand smoke contains not only poisons such as hydrocyanic acid, ammonia, and carbon monoxide, but also numerous carcinogenic substances including polycyclic aromatic hydrocarbons, N-nitrosamines, aromatic amines, benzene, vinyl chloride, arsenic, cadmium, chromium and the radioactive isotope polonium 210,” states Dr. Martina Pötschke-Langer, the editor of the publication. “For the carcinogenic substances contained in secondhand smoke it is impossible to determine threshhold values under which no health risk is to be expected. Even the slightest exposure can contribute to the development of tumors.”
In Germany, the level of pollution due to tobacco smoke is considerable: Each year more than 170,000 newborn babies have already been exposed in the womb to the harmful substances contained in tobacco smoke, and an estimated 8 million or more children and teenagers under 18 years old live in a household with at least one smoker. Among the adult population, more than 35 million nonsmokers are forced to inhale the harmful substances contained in secondhand smoke – at home, at work, or in their leisure time. At the workplace alone, about 8.5 million nonsmokers are still exposed to secondhand smoke.
Secondhand smoke irritates the respiratory tract and can lead to breathlessness during physical activity, increased susceptibility to infection, headaches and dizziness. Even a short exposure can elicit these symptoms. However, secondhand smoke is also a contributory factor in the causation of chronic and fatal diseases.
The joint authors of the study, the epidemiologists Professor Dr. Ulrich Keil of the University of Muenster and Professor Dr. Heiko Becher of Heidelberg University made the first ever calculation of the annual number of fatalities in Germany due to secondhand smoke: “Every year, secondhand smoke causes the deaths of an estimated 2140 nonsmokers due to coronary heart disease, 770 nonsmokers due to stroke, 50 nonsmokers due to chronic obstructive pulmonary disease, and 260 nonsmokers due to lung cancer. Approximately 60 infants die each year as a result of secondhand smoke in the household or from prenatal exposure to harmful substances, because the mother smoked during pregnancy,” explain Ulrich Keil and Heiko Becher.
The two epidemiologists emphasize: “In Germany, more than 3300 nonsmokers probably die each year as a consequence of exposure to secondhand smoke. This is a larger number of fatalities than the annual toll from illegal drugs, asbestos, BSE and SARS combined.”
Secondhand smoke is also a contributory factor in the occurrence of numerous non-fatal cases of coronary heart disease, stroke, and chronic obstructive pulmonary disease.
Dr. Martina Pötschke-Langer considers the present level of exposure of nonsmokers to tobacco smoke in Germany as inacceptable. In view of the estimated 3300 or more annual deaths and the countless persons who are ill because of secondhand smoke, it is urgent that a federal bill be introduced to ensure comprehensive protection of nonsmokers in public premises, including restaurants. An information campaign in Germany, drawing attention to the dangers of secondhand smoke would also contribute to reducing the number of victims. Germany needs to take action!
The publication “Passivrauchen - ein unterschätztes Gesundheitsrisiko“ (“Secondhand smoke – an underestimated health risk”) was authored by scientists from the German Cancer Research Center (DKFZ), Heidelberg, the Institute for Epidemiology and Social Medicine of the University of Muenster, and the Hygiene Institute of the Heidelberg University Hospital. It can be obtained as a pdf file from www.tabakkontrolle.de and in printed form from:
WHO Collaborative Center for Tobacco Control
Fax: +49 6221 42 30 20
or by e-mail: email@example.com
The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) with its more than 2,500 employees is the largest biomedical research institute in Germany. At DKFZ, more than 1,000 scientists investigate how cancer develops, identify cancer risk factors and endeavor to find new strategies to prevent people from getting cancer. They develop novel approaches to make tumor diagnosis more precise and treatment of cancer patients more successful. The staff of the Cancer Information Service (KID) offers information about the widespread disease of cancer for patients, their families, and the general public. Jointly with Heidelberg University Hospital, DKFZ has established the National Center for Tumor Diseases (NCT) Heidelberg, where promising approaches from cancer research are translated into the clinic. In the German Consortium for Translational Cancer Research (DKTK), one of six German Centers for Health Research, DKFZ maintains translational centers at seven university partnering sites. Combining excellent university hospitals with high-profile research at a Helmholtz Center is an important contribution to improving the chances of cancer patients. DKFZ is a member of the Helmholtz Association of National Research Centers, with ninety percent of its funding coming from the German Federal Ministry of Education and Research and the remaining ten percent from the State of Baden-Württemberg.